Publications by authors named "Akari Shigemi"

Claim this Profile
P
Pitt candidaemia score as an assessment tool for mortality in patients with candidaemia caused by and other species: a multicentre study conducted in Japan.
Takashi Ueda, Hiroshi Kakeya, Koichiro Yoshida, Akihiro Hisato, Akira Ukimura, Akari Shigemi

JAC Antimicrob Resist· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and development of population pharmacokinetic model of vancomycin using a real-world database from a nationwide free web application.
Kazutaka Oda, Kazuaki Matsumoto, Kensuke Shoji, Akari Shigemi, Hideki Kawamura

J Infect Chemother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cohort study of the risk factors and the target AUC to avoid vancomycin-associated acute kidney injury in pediatric patients.
Naoko Kanazawa, Akari Shigemi, Nao Amadatsu, Kotaro Arimura, Shohei Shimono

J Infect Chemother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced measures, including PCR-based screening and syndromic surveillance for nosocomial outbreaks of the COVID-19 Omicron variant, using descriptive epidemiology and whole-genome sequencing in a Japanese tertiary care hospital.
Hideki Kawamura, Shoko Arimura, Ryuichi Saida, Nao Murata, Akari Shigemi

J Infect Chemother· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-informed precision dosing of vancomycin for rapid achievement of target area under the concentration-time curve: A simulation study.
Kazutaka Oda, Tomoyuki Yamada, Kazuaki Matsumoto, Yuki Hanai, Takashi Ueda, Akari Shigemi

Clin Transl Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-informed precision dosing of teicoplanin for the rapid achievement of the target area under the concentration-time curve: A simulation study.
Kazutaka Oda, Tomoyuki Yamada, Kazuaki Matsumoto, Yuki Hanai, Takashi Ueda, Akari Shigemi

Clin Transl Sci· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concentration-Dependent Activity of Pazufloxacin against : An In Vivo Pharmacokinetic/Pharmacodynamic Study.
Yasuhiro Umezaki, Kazuaki Matsumoto, Kazuro Ikawa, Yuta Yokoyama, Yuki Enoki, Akari Shigemi

Antibiotics (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candidates for area under the concentration-time curve (AUC)-guided dosing and risk reduction based on analyses of risk factors associated with nephrotoxicity in vancomycin-treated patients.
Naoto Hashimoto, Toshimi Kimura, Yukihiro Hamada, Takashi Niwa, Yuki Hanai, Akari Shigemi

J Glob Antimicrob Resist· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing Optimization of Ampicillin-Sulbactam Based on Cystatin C in Elderly Patients with Pneumonia.
Kayoko Matsubara, Kazuaki Matsumoto, Yuta Yokoyama, Erika Watanabe, Yuki Enoki, Akari Shigemi

Biol Pharm Bull· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/pharmacodynamic evaluation of teicoplanin against Staphylococcus aureus in a murine thigh infection model.
Erika Watanabe, Kazuaki Matsumoto, Kazuro Ikawa, Yuta Yokoyama, Akari Shigemi

J Glob Antimicrob Resist· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A meta-analysis of the target trough concentration of gentamicin and amikacin for reducing the risk of nephrotoxicity.
Tomoyuki Yamada, Satoshi Fujii, Akari Shigemi, Yoshio Takesue

J Infect Chemother· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan.
Yukihiro Hamada, Takashi Ueda, Yoshitsugu Miyazaki, Kazuhiko Nakajima, Keiko Fukunaga, Akari Shigemi

Mycoses· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of GST polymorphisms on busulfan pharmacokinetics in Japanese children.
Takuro Nishikawa, Hiroki Yamaguchi, Kazuro Ikawa, Kazutaka Nakayama, Erika Higashi, Akari Shigemi

Pediatr Int· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring of voriconazole in Japanese patients: analysis based on clinical practice data.
Kazuaki Matsumoto, Kazuko Abematsu, Akari Shigemi, Naoko Kanazawa, Erika Watanabe

J Chemother· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections.
Kazuaki Matsumoto, Erika Watanabe, Naoko Kanazawa, Tomohide Fukamizu, Akari Shigemi

Clin Pharmacol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bundle that includes active surveillance, contact precaution for carriers, and cefazolin-based antimicrobial prophylaxis prevents methicillin-resistant Staphylococcus aureus infections in clean orthopedic surgery.
Hideki Kawamura, Kazuaki Matsumoto, Akari Shigemi, Michiyo Orita, Aya Nakagawa

Am J Infect Control· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for ganciclovir-induced thrombocytopenia and leukopenia.
Kazuaki Matsumoto, Akari Shigemi, Kazuro Ikawa, Naoko Kanazawa, Yuko Fujisaki

Biol Pharm Bull· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting treatment and recurrence of Clostridium difficile infections.
Kazuaki Matsumoto, Naoko Kanazawa, Akari Shigemi, Kazuro Ikawa, Norifumi Morikawa

Biol Pharm Bull· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics.
Kazuaki Matsumoto, Akari Shigemi, Ayumi Takeshita, Erika Watanabe, Yuta Yokoyama

J Infect Chemother· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.
Kazuaki Matsumoto, Akari Shigemi, Ayumi Takeshita, Erika Watanabe, Yuta Yokoyama

Int J Antimicrob Agents· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.
Yuta Yokoyama, Kazuaki Matsumoto, Kazuro Ikawa, Erika Watanabe, Akari Shigemi

Int J Antimicrob Agents· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction in the incidence of MRSA with use of alcohol-based hand rub solutions and gloves.
Kazuaki Matsumoto, Akari Shigemi, Keiko Yaji, Yoshihiro Shimodozono, Yasuo Takeda

J Infect Chemother· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety analysis of liposomal amphotericin B in adult patients: anaemia, thrombocytopenia, nephrotoxicity, hepatotoxicity and hypokalaemia.
Akari Shigemi, Kazuaki Matsumoto, Kazuro Ikawa, Keiko Yaji, Yoshihiro Shimodozono

Int J Antimicrob Agents· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An initial dosing method for teicoplanin based on the area under the serum concentration time curve required for MRSA eradication.
Naoko Kanazawa, Kazuaki Matsumoto, Kazuro Ikawa, Tomohide Fukamizu, Akari Shigemi

J Infect Chemother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.
Kazuaki Matsumoto, Ayumi Takeshita, Kazuro Ikawa, Akari Shigemi, Keiko Yaji

Int J Antimicrob Agents· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis